Specialty billing · Rheumatology
One of the few office specialties that runs a small pharmacy inside the exam suite.
247 Medical Billing Services delivers rheumatology billing services that protect the drug revenue at the center of your practice — buy-and-bill biologics, timed infusions, joint injections, and prior authorization across Medicare, Medicaid, and commercial payers. You get a dedicated account manager, a free 360° reporting dashboard, and HIPAA- and SOC 2-compliant workflows built by a team that has run rheumatology revenue cycles since 2005.
Rheumatology is one of the few office specialties that runs a small pharmacy inside the exam suite, and that single fact reshapes the entire revenue cycle. One infliximab or rituximab infusion can carry more revenue — and more exposure — than a full week of office visits, so the drug, not the visit, is what determines whether a month lands in the black.
A general biller who treats an autoimmune claim like a routine E/M encounter leaves money on the table every cycle.
You buy the biologic and hold it before a single dollar comes back.
Not to the vial, and not to the order — to what was actually administered.
The discarded portion of a single-dose vial is its own line, with its own modifier.
Secured before the needle goes in — a dose infused early is simply an unpaid dose.
Buy the biologic, store it, infuse it, and bill for both the product and the administration correctly, and it pays cleanly and predictably. We built our rheumatology billing services around that reality — closing each gap at the front end so more claims pay on the first pass, fewer dollars get clawed back, and your clinical team never stops mid-infusion to settle a coding question.
We manage each moving part so a claim is paid to its true value — nothing bundled away, nothing left uncaptured, nothing billed in a way that invites a takeback:
| Where money is won or lost | What it is | What we manage |
|---|---|---|
| Buy-and-bill drug | The biologic itself, reported under its HCPCS J-code by exact billed units | Units reconciled to the dose administered, NDC captured, single-dose-vial waste billed on a separate line with modifier JW and zero-waste attested with JZ |
| Infusion & injection administration | Timed CPT hierarchy 96365–96417 plus therapeutic injection 96372 | Correct initial-versus-sequential/concurrent hierarchy, hour and each-additional-hour units, and push-versus-infusion distinction tied to the nurse's documented times |
| Joint & soft-tissue injections | Arthrocentesis/injection 20600–20611, split by joint size and ultrasound guidance | Right size tier, guidance code 76942 when documented, laterality and per-joint units, and modifier 25 on a truly separate same-day visit |
| Bone density & lab monitoring | DEXA 77080/77081 and the drug-safety labs immunosuppressants require | Frequency tracked against coverage rules, diagnoses linked to medical necessity, and monitoring labs coded to the ordering intent |
| E/M complexity & prolonged care | High-MDM visits, often with prolonged time (99417) | Level supported by decision-making and time in the record, prolonged service captured, and the visit protected when billed alongside a procedure |
| Prior authorization & step therapy | Payer approval and preferred-agent failure rules on biologics | Authorization secured before infusion, step-therapy history documented, and the approval span tracked so no dose is given uncovered |
Each of these is a place where autoimmune care quietly leaks revenue. Buy-and-bill biologics have to be reported in exact units against the HCPCS descriptor, with any discarded portion of a single-dose vial captured on its own waste line — or the practice eats the difference. Administration is timed, tiered, and constantly mis-mapped to chair time rather than to the initial-versus-sequential hierarchy the payer actually pays on. Nearly every biologic requires prior authorization and most carry step-therapy edits, so a dose infused early is simply an unpaid dose. Joint injections turn on the small-versus-large distinction, laterality, and documented guidance. And the office visit itself — managing immunosuppressants, ordering the labs they require, coordinating infusions — is genuine high-complexity decision-making that is routinely billed a level low.
Outsourcing makes more sense in rheumatology than in almost any office specialty, precisely because the margin lives in the pharmacy rather than the front desk.
An in-house biller has to master buy-and-bill drug reconciliation, JW/JZ waste rules, the timed infusion hierarchy, joint-injection tiers, and biologic step therapy all at once — and when that one person is on vacation or leaves, the highest-dollar claims in the practice are the ones sitting unworked. The cost of a single mishandled biologic line can exceed a month of billing fees, so the risk of keeping that expertise on a single desk is out of proportion to the savings.
When you outsource rheumatology billing services to us, that specialized knowledge stops being a staffing gamble and becomes a standing capability. A certified team already fluent in autoimmune coding works your claims on a transaction-based fee, the high-dollar infusion lines get prioritized every day, and you replace the fixed cost — and single point of failure — of an in-house specialist with a bench that never takes a day off.
Everything it takes to move a rheumatology claim from the infusion note to paid, run by one certified team rather than split across vendors:
Biologics reported by exact units under the correct HCPCS descriptor, waste captured with the right modifier, and timed administration coded to the nurse's documented start and stop times so the drug and the chair both pay fully.
Biologic and targeted-synthetic authorizations obtained before the drug is drawn up, preferred-agent failures documented to clear step edits, and approval spans tracked so nothing is infused outside its coverage window.
Coverage, medical-versus-pharmacy benefit routing, network status, and authorization requirements confirmed before the visit, not discovered after the denial.
Every denial worked to root cause, including medical-necessity, step-therapy, unit-mismatch, and bundling denials, appealed inside each payer's clock.
Aged claims pursued relentlessly across Medicare, commercial, and Medicaid payers, with the high-dollar infusion lines prioritized so nothing large ages out.
The whole cycle run as one connected process, from verification through posting, on a live dashboard your named account manager reviews with you.
If you'd rather keep rheumatology billing and coding services under one roof, that's exactly the model — certified coders and billers on the same team, sharing the same record, instead of handing your claims back and forth between companies.
Revenue review
We'll put a dollar figure on what your under-billed infusions, denied injections, and stalled prior authorizations are actually costing.
A rheumatology billing specialist will reach out within one business day.
A rheumatology billing specialist will reach out within one business day.
Choosing us is not the same as hiring a general biller who happens to accept infusion claims. It's engaging a rheumatology billing company that already knows where autoimmune revenue leaks:
We hold a 98% client-retention rate because those numbers hold month after month:
A generalist learns buy-and-bill rheumatology on your claims. We show up already fluent in it — and the difference shows up on the remittance:
Most rheumatology losses trace back to the same handful of failure points. We close each one at the front end, before it becomes a denial or a recoupment. Procedure, drug, and coverage codes are noted here for precision:
Drug units billed that don't match the dose administered
Unit-mismatch denial and recoupment on a high-dollar J-code
We reconcile billed units to the documented dose and attach the NDC before submission
Single-dose-vial waste dropped or unattested (missing JW/JZ)
Lost waste reimbursement or overpayment audit exposure
We bill discarded amount on a separate JW line and attest zero waste with JZ on every single-dose vial
Infusion administration billed without the initial/sequential hierarchy (96365–96417)
Administration downcode to a single unit
We code the primary service once and layer sequential/concurrent and additional-hour units to the nurse's times
Biologic infused before prior authorization or step therapy clears
Full denial of the drug and the administration
We secure authorization and document preferred-agent failure before the drug is drawn up
Joint injection (20600–20611) without documented guidance or laterality
Downcode, bundling, or medical-necessity denial
We match the size tier, add guidance (76942) when documented, and apply laterality and per-joint units
Same-day E/M without modifier 25 alongside an injection or infusion
E/M denial
We append modifier 25 only when the visit is genuinely separate and significant
Every one of these is preventable before submission rather than argued after the fact. Request a revenue review and we'll show you which of them is hitting your remits right now.
The rules shift with the setting and the drug mix, and we bill each one to the detail it demands:
Solo and small-group clinics where a handful of infusions each week carry a large share of the month's collections, and one mishandled drug line is felt immediately.
What decides the moneyA handful of infusions each week
Higher volumes across biologics, injections, and complex office visits, where consistent coding and authorization discipline decide the bottom line.
What decides the moneyConsistency and authorisation discipline
Buy-and-bill and administration billing where drug reconciliation, waste capture, and timed hierarchy are the whole game.
What decides the moneyReconciliation, waste and hierarchy
Split professional and facility billing, teaching-physician documentation, and heavy prior-authorization loads on advanced therapies.
What decides the moneySplit billing under a heavy auth load
Shared infusion and joint-injection roots; see our related oncology billing services for buy-and-bill chemotherapy and our orthopedic billing services for the joint-procedure side.
What decides the moneyBoth roots coded to their own rules
Changing billers shouldn't mean a gap in cash flow, and with us it doesn't.
We work inside your existing practice-management and EHR systems, so nobody has to relearn a platform, and credentialing and payer-enrollment review run in parallel while your claims keep going out the door.
Before the first claim goes out under our name, we reconcile your open A/R, map your payer mix and fee schedules, and confirm which biologics are running through the medical benefit versus the pharmacy benefit.
From there your account manager reports on the same live dashboard you'll use going forward, so you can watch the transition play out rather than waiting on a monthly summary. Most practices are fully live within a few weeks.
The denial drop and the faster A/R show up in the first cycles, not a quarter later — and the high-dollar infusion lines are the first thing we stabilize.
Protect the revenue that actually decides your month — the infused biologic, not the office visit.
A single vial can outweigh a week of encounters and behaves like nothing else on the fee schedule, so we build the claim around the drug: every line reconciled to the documented dose, waste captured with the correct modifier on its own line, the timed administration hierarchy coded to the nurse's start and stop times, and the authorization verified before the drug is drawn up. That is precisely where a general biller leaves money behind, treating an autoimmune claim like a routine E/M encounter. Because one mishandled biologic line can exceed a month of fees, getting each rule right at the front end is the whole job — and it is why our rheumatology medical billing holds first-pass clean claims near 99%, denials down up to 40%, and days in A/R under 25. Request a revenue review
The failures that turn a vial into a denial
The rheumatology billing services provider worth hiring treats the infused drug as the economic engine it is — not as just another line item. We catch billed units that don't match the dose, single-dose-vial waste dropped without its modifier, and a biologic infused before step therapy cleared.
A general rheumatology billing company can post payments and refile denials, but protecting autoimmune drug revenue takes a team that reconciles drug units and NDCs, codes the timed administration hierarchy correctly, and secures prior authorization ahead of the infusion.
NAMEDAn account manager who owns your accountFRONTInfusion lines front and centre on the dashboardFREENo long-term lock-inA partner built to protect your drug revenue, not simply process the professional fee.
Request a Revenue ReviewWhat changes hands
Outsource rheumatology billing to 247MBS and the specialized knowledge that protects your drug revenue stops being a staffing gamble and becomes a standing capability. A certified team already fluent in buy-and-bill reconciliation, JW/JZ waste rules, and the timed infusion hierarchy works your claims every day — not one biller who becomes a single point of failure the week they take leave.
Outsourcing rheumatology billing services here means the highest-dollar infusion lines are prioritized first and worked to payment, month after month, while your clinical team never stops mid-infusion to settle a coding question.
Rheumatology billing services outsourcing with us stays fully visible: a named account manager owns the relationship and a free 360° dashboard shows every claim, denial, and dollar in real time. You trade the fixed cost — and the single point of failure — of an in-house specialist for a transaction-based model that scales with your volume, and because a single drug line can dwarf the professional fee, that trade almost always pays for itself. See what your infusions should really collect — request a revenue review or call +1 888-502-0537.
FIRSTThe highest-dollar infusion lines, prioritisedREAL TIMEEvery claim, denial and dollar on the dashboardSCALESA transaction-based model, not a fixed costWhether you're a solo rheumatologist, a multi-provider group, an in-office infusion suite, or a hospital-affiliated clinic, our rheumatology billing services protect every biologic, every injection, and every dollar of aged A/R. Partner with a rheumatology billing services company that treats buy-and-bill drug reconciliation, timed administration, prior authorization, and injection coding as routine — and put the revenue you're leaving on the table back where it belongs.
Prefer email? sales@247medicalbillingservices.com